GSH(Glutathione) ELISA Kit
中文名称:谷胱甘肽(GSH)酶联免疫吸附测定试剂盒
别称:
GSH
Price:
Size:
96T
48T
96T*5
- 反应性: Universal
- 检测范围: 1.56-100 μg/mL
- 灵敏度: 0.94 μg/mL
产品应用 | ELISA |
检测原理 | 本试剂盒采用竞争ELISA法。用GSH抗原包被于酶标板上,实验时样品或标准品中的GSH与包被的GSH竞争生物素标记的抗GSH单抗上的结合位点,游离的成分被洗去。加入辣根过氧化物酶标记的亲和素,生物素与亲和素特异性结合而形成免疫复合物,游离的成分被洗去。加入显色底物(TMB),TMB在辣根过氧化物酶的催化下呈现蓝色,加终止液后变成黄色。用酶标仪在450nm波长处测OD值,GSH浓度与OD450值之间呈反比,通过绘制标准曲线计算出样品中GSH的浓度。 |
反应类型 | Competitive-ELISA |
规格 |
96T
/ 48T
/ 96T*5
|
反应时间 | 2.5h |
反应性 | Universal |
检测方法 | 比色法 |
检测范围 | 1.56-100 μg/mL |
灵敏度 | 0.94 μg/mL |
样本体积 | 50μL |
样本类型 | 血清,血浆,细胞上清,细胞提取液体,组织匀浆等其他生物体液 |
特异性 | 可检测样本中的GSH,且与其它类似物无明显交叉反应 |
精密度 | 板内,板间变异系数均<10% |
回收率 | 80%-120% |
储存条件 | 2-8℃/-20℃ |
数据处理 |
-
Protective effect of pterostilbene in a streptozotocin-induced mouse model of Alzheimer's disease by targeting monoamine oxidase B
IF: 3.628 -
Hepatoprotective and neuroprotective effect of taxifolin on hepatic encephalopathy in rats
IF: 3.584 -
A low direct electrical signal attenuates oxidative stress and inflammation in septic rats
IF: 3.24 -
Perindopril ameliorates experimental Alzheimer’s disease progression: role of amyloid β degradation, central estrogen receptor and hyperlipidemic-lipid raft signaling
IF: 3.238Journal:INFLAMMOPHARMACOLOGY -
Therapeutic Effects of Salvianolic Acid B on Angiotensin II–Induced Atrial Fibrosis by Regulating Atrium Metabolism via Targeting AMPK/FoxO1/miR-148a-3p Axis
IF: 3.216Journal:Journal of Cardiovascular Translational Research -
Antioxidant and DNA protective effects of NTX, a proprietary glycyrrhizin/d-mannitol product, in association with alcohol consumption: A randomized, placebo-controlled, double-blind, crossover study
IF: 3.144Journal:Journal of Functional Foods -
Neuroprotective effects of brain‐derived neurotrophic factor against amyloid beta 1‐40‐induced retinal and optic nerve damage
IF: 3.115Journal:EUROPEAN JOURNAL OF NEUROSCIENCE -
Syringic acid protects against thioacetamide-induced hepatic encephalopathy: Behavioral, biochemical, and molecular evidence
IF: 3.046 -
Limonin modulated immune and inflammatory responses to suppress colorectal adenocarcinoma in mice model
IF: 3 -
Effect of Helicobacter pylori-eradication therapy on hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomized–controlled pilot study
IF: 2.96Journal:Gastroenterology Report